Microbiome innovation for animal health

The problem

With a lack of innovation in the field of animal medicine, new tools are needed to keep production animals and pets healthy and productive.

The solution

Harnessing the microbiome to discover and develop novel probiotics, microbiome-derived bioactives, and engineered microbial therapeutics.

Our engagement

Anterra helped orchestrate the spinout from Elanco and participated in the Series A financing. Co-investors and partners include Viking Global, Elanco, Ginkgo Bioworks & The Ferment Fund, and Nutreco.